Fig. 1From: Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fractionEchocardiographic data at baseline and after 60 days of S/V treatment. LVESVi: Indexed left ventricular end-systolic volume. LVEDVi: Indexed left ventricular end-diastolic volume. LVEF: Left ventricular ejection fraction. Means ± se; **p < 0.01Back to article page